Keyphrases
Academic Productivity
19%
Adjusted Hazard Ratio
23%
Adjusted Odds Ratio
39%
Angiotensin Receptor Blockers
24%
Autonomous Cortisol Secretion
38%
Blood Pressure
44%
Body Mass Index
77%
Chronic Kidney Disease
25%
Confidence Interval
33%
Dexamethasone Suppression Test
29%
During Pregnancy
23%
Dysglycemia
22%
Early Invasive Strategy
19%
Early Renal Injury
19%
Estimated Glomerular Filtration Rate
19%
First Trimester
42%
Hazard Ratio
52%
Heart Failure Patients
19%
Hypertension
50%
Ischemic Stroke
29%
Israeli Adolescents
21%
Low Body Weight
19%
Major Congenital Malformations
26%
Major Malformations
31%
Malformation
26%
Metabolic Derangements
21%
Metabolic Syndrome
22%
Military Service
28%
Myocardial Infarction Patients
21%
National Cohort Study
36%
Non-associated
45%
Non-coronary
19%
Normetanephrine
19%
Older Adults
63%
Pharmacovigilance
38%
Population-based Retrospective Cohort Study
43%
Pregnancy Outcome
19%
Pregnancy Trimester
28%
Propensity Score Matching
23%
Safety Profile
24%
Sensitivity Analysis
21%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
21%
Spina Bifida
19%
ST-elevation Myocardial Infarction (STEMI)
58%
Stroke in the Young
38%
Systolic Blood Pressure
33%
Temporal Perception
19%
Urinary Tract Cancer
19%
Young Adulthood
97%
Young-onset Hypertension
43%
Medicine and Dentistry
Adolescent
100%
Adrenal Adenoma
19%
Angiotensin Receptor Antagonist
19%
Apoplexy
19%
Blood Pressure
21%
Blood Pressure Reduction
19%
Body Mass Index
50%
Cancer
19%
Catecholamine
19%
Childbirth
19%
Chronic Kidney Disease
38%
Clonidine
19%
Cohort Analysis
26%
Congenital Malformation
28%
COVID-19
19%
Dexamethasone Suppression Test
29%
Disease
19%
Dysglycemia
21%
Ejection Fraction
19%
End Stage Renal Disease
19%
Enkephalinase Inhibitor
19%
First Trimester Pregnancy
25%
Frailty
19%
Ganglioneuroma
19%
Glomerular Filtration Rate
18%
Hazard Ratio
56%
Heart Failure
19%
Heart Ventricle Remodeling
19%
Hematuria
19%
Hydrocortisone
29%
Hydrocortisone Release
38%
Kidney Injury
21%
Maturity Onset Diabetes of the Young
19%
Metanephrine
19%
Myocardial Infarction
34%
Myocarditis
19%
Non ST Segment Elevation Myocardial Infarction
38%
Nonalcoholic Fatty Liver
19%
Normetanephrine
19%
Odds Ratio
31%
Omicron Coronavirus Variant
19%
Opiate
19%
Pharmacovigilance
19%
Proportional Hazards Model
19%
Pyrrole Derivative
19%
Retrospective Cohort Study
31%
Sodium Glucose Cotransporter 2 Inhibitor
19%
Systolic Blood Pressure
19%
Urinary Tract Cancer
19%
Vagina Candidiasis
19%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
11%
Adrenal Cortex Adenoma
19%
Adrenal Incidentaloma
9%
Adverse Event
10%
All Cause Mortality
12%
Amoxicillin
19%
Angioneurotic Edema
9%
Angiotensin Receptor Antagonist
25%
Brain Ischemia
19%
Cardiovascular Risk
19%
Catecholamine
19%
Chronic Kidney Failure
19%
Clavulanic Acid
19%
Clonidine
19%
Cohort Study
91%
Congenital Malformation
50%
Coronavirinae
19%
Cross-Sectional Study
21%
Dexamethasone
21%
Disease
29%
Dysglycemia
19%
End Stage Renal Disease
19%
Enkephalinase Inhibitor
19%
Enoxaparin
19%
Frailty
19%
Heart Failure
22%
Heart Infarction
34%
Heart Ventricle Remodeling
19%
Hemoglobin A1c
7%
Hydrocortisone
38%
Hyperkalemia
9%
Hypotension
14%
Infection
10%
Kidney Injury
21%
Metabolic Syndrome X
11%
Metadrenalin
19%
Myocarditis
19%
Non ST Segment Elevation Myocardial Infarction
38%
Noradrenalin
17%
Normetadrenalin
19%
Obesity
14%
Opiate
19%
Pharmacovigilance
38%
Population Study
14%
Pyrrole Derivative
19%
Renal Diabetes
19%
Sodium Glucose Cotransporter 2 Inhibitor
21%
Spinal Dysraphism
10%
Vagina Candidiasis
19%
Valsartan/Sacubitril
19%